Additional Activities

ACC.18 isn't just about world-class cardiovascular education! It's also a place to connect with your colleagues, look for a new job, or discuss the latest in your specialty area.

  Networking Events
  Networking Events

ACC.18 is the host to many of the ACC’s section meetings which will take place throughout the three days. It’s a great time to connect with colleagues and friends with similar interests and get involved with initiatives and activities related to your special interest area.

Additional Activities

  Friday, March 9
  Friday, March 9

Training Program Administrators, Day 1
7:00 a.m. – 1:00 p.m.
Hyatt Regency Orlando, Plaza International Ballroom D

Division Chiefs Meeting
9:30 a.m. – 11:30 a.m.
Hyatt Regency Orlando, Plaza International Ballroom E/F

CHD Community Day
1:00 p.m. – 6:00 p.m.
Hyatt Regency Orlando, Plaza International Ballroom E/F

Task Force on Diversity: Town Hall
4:00 p.m. – 6:00 p.m.
Hyatt Regency Orlando, Regency Ballroom T

ACC.org Editorial Reception
6:00 p.m. – 7:00 p.m.
Hyatt Regency Orlando, Celebration 6

ACCPAC Signature Event
6:00 p.m. – 8:00 p.m.
Hyatt Regency Orlando, Orlando Ballroom M

  Saturday, March 10
  Saturday, March 10

Training Program Administrators, Day 2
7:00 a.m. – 4:30 p.m.
Hyatt Regency Orlando, Plaza International Ballroom D

Careers in Heart Failure & Transplant Symposium
4:30 p.m. – 6:00 p.m.
Hyatt Regency Orlando, Regency Ballroom Q

Women in Cardiology Section Meeting
5:00 p.m. – 7:00 p.m.
Hyatt Regency Orlando, Regency Ballroom T

CV Team Section Meeting & Reception
5:00 p.m. – 7:30 p.m.
Hyatt Regency Orlando, Orlando Ballroom N

Health Care Innovation Section Information Session
6:00 p.m. – 7:00 p.m.
Hyatt Regency Orlando, Celebration 1

JACC Journals Author/Editor Meet & Greet
6:30 p.m. – 8:00 p.m.
Hyatt Regency Orlando, Plaza International Ballroom K

ACC International Members Reception
6:30 p.m. – 8:00 p.m.
Hyatt Regency Orlando, Plaza International Ballroom F

  Sunday, March 11
  Sunday, March 11

Training Program Administrators, Day 3
7:00 a.m. – 12:30 p.m.
Hyatt Regency Orlando, Plaza International Ballroom D

Federal Cardiology Section Meeting
12:00 p.m. – 2:00 p.m.
Hyatt Regency Orlando, Plaza International Ballroom I

Adult Congenital & Pediatric Cardiology Quality Network Learning Session
1:00 p.m. – 3:30 p.m.
Hyatt Regency Orlando, Celebration 7

APC General Assembly
3:00 p.m. – 5:00 p.m.
Hyatt Regency Orlando, Orlando Ballroom L

Geriatric Cardiology Section Meeting, Reception & Poster Session
4:45 p.m. – 6:15 p.m.
Hyatt Regency Orlando, Plaza International Ballroom I/J

Peripheral Vascular Disease Section Meeting
5:00 p.m. – 6:15 p.m.
Hyatt Regency Orlando, Celebration 7

ACPC Section Meeting
5:00 p.m. – 6:30 p.m.
Hyatt Regency Orlando, Plaza International Ballroom E/F

Emerging Faculty Alumni Reception
6:30 p.m. to 7:30 p.m.
Hyatt Regency Orlando, Upper Pool Deck

All Sections Reception
6:30 p.m. – 8:00 p.m.
Hyatt Regency Orlando, Orlando Ballroom M/N

  Monday, March 12
  Monday, March 12

67th Annual Convocation
6:30 p.m. – 8:00 p.m.
ACC.18 Main Tent, Hall C

President's, New Fellows' and Associates' Reception
8:00 p.m. – 9:00 p.m.
Hyatt Regency Orlando, Plaza International Ballroom G/H

  Independent Certified Sessions
  Independent Certified Sessions

Independent Certified Sessions are educational programs organized by a non-profit organization that offer continuing medical education (CME), continuing nursing education (CNE) and/or continuing education (CE) credit and for which no commercial support has been received.

Friday, March 9

Managing Valvular and Thoracic Aortic Disease: What Every Cardiologist Should Know in 2018
7:00 p.m. – 9:30 p.m.
Hilton Orlando

Thoracic aortic diseases are usually asymptomatic and not easily detectable until an acute and often catastrophic complication occurs, thus the importance of early recognition and prompt treatment and/or referral for various thoracic aortic diseases by all healthcare professionals is critical. Often, it is associated with concomitant aortic valve disease. This program will present risk factors for thoracic aortic disease, evidence of who may benefit from screening, recommended imaging modalities and treatment options so that appropriate care of these patients can be facilitated and better understood. Register today.

Sponsored by Cleveland Clinic

Managing Complex Challenges in Heart Failure: Integrating Advances in Therapies from Multiple Disciplines
7:00 p.m. – 9:30 p.m.
Rosen Centre

The contemporary management of heart failure is characterized by evolving strategies to combine newer approaches based on research advances with well-established evidence-based standards of care. Optimal patient outcomes require a multidisciplinary approach with coordination among several traditionally compartmentalized subspecialties, including heart failure, imaging, EP and cardiac surgery. The program will illustrate how a synchronized program may be built in tertiary care centers. The agenda will follow a case-based approach to illustrate the timings of various interventions and the benefits of multidisciplinary management. Register today.

Sponsored by Cleveland Clinic and Valley Health System

  Prime Time Events
  Prime Time Events

Prime Time Events are offered by companies and organizations at various venues throughout Orlando. Be sure to check back frequently to see the non-certified educational events that you'll want to add to your ACC.18 schedule.

  Friday, March 9
  Friday, March 9

Evening Events

RNA Interference: A New Horizon for LDL-C Reduction
Registration and Dinner: 5:30 p.m. – 6:30 p.m.
Program beings: 6:30 p.m.
Hyatt Regency Orlando, Windemere X Ballroom
Sponsored by The Medicines Company

Eugene Braunwald, MD; Distinguished Hersey Professor of Medicine at Harvard Medical School, Founding Chairman of the TIMI Study Group
John J.P. Kastelein, MD, PhD; Professor of Medicine and Chairman of the Department of Vascular Medicine at the Academic Medical Center of the University of Amsterdam, University of Amsterdam
Rory Collins, FMedSci, FRS; British Heart Foundation Professor of Medicine and Epidemiology at the University of Oxford, Principal Investigator and Chief Executive at UK Biobank
John Maraganore, MD, PhD; Chief Executive Officer, Alnylam, Chair, BIO
Brian Ference, MD, MPhil., MSc; Associate Chief, Division of Translational Research and Clinical Epidemiology (TRaCE), Director, Cardiovascular Genomic Research Center, Assistant Professor of Medicine Wayne State University School of Medicine
Kausik Ray, MD, MPhil, Professor of Public Heath, Department of Public Health and Primary Care Imperial College of London
Marc Sabatine, MD, MPH
Lewis Dexter, MD, Distinguished Chair in Cardiovascular Medicine at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School , Chairman of the TIMI Study Group
Louise Bowman, BA, MBBS, MRCP, MD; Associate Professor of Clinical Trials and Epidemiology & Honorary Consultant Physician (Lipidology) at the University of Oxford
Clive Meanwell, MD, PhD; Chief Executive Officer, The Medicines Company

Two profound scientific advances make possible a new horizon in atherosclerotic disease: The discovery of an RNA interference mechanism that silences only the gene of interest and the identification of mutations in the gene encoding PCSK9. Drs. Eugene Braunwald and John Kastelein co-chair this symposium which describes how these advances have led to a new LDL-C lowering investigational drug, inclisiran, and the progress made on its clinical development

The Interventional Toolbox for Complete Revascularization in Higher-Risk (and Indicated) Patients (CHIP)
Registration: 6:00 p.m. – 6:30 p.m.
Program: 6:30 p.m. – 9:00 p.m.
Hilton Orlando, Orange Ballroom D
Sponsored by Cardiovascular Research Foundation (CRF)

Ajay J. Kirtane, MD, SM
Martin B. Leon, MD
William L. Lombardi, MD
Jeffrey W. Moses, MD

This program is geared toward interventionalists seeking to better understand the latest learning on complex PCI. Presentations address case selection and treatment of complex patient and lesion subsets, such as those with left main coronary artery disease, chronic total occlusions, bifurcation lesions, severe calcification, and depressed ventricular function. Expert faculty will offer valuable insights into selecting appropriate patients for coronary revascularization and optimizing technique. Attendees will have the opportunity to assess and discuss these approaches in an interactive format.

  Saturday, March 10
  Saturday, March 10

Evening Events

Life and Death Decisions for TAVR Eligible Patients
6:30 p.m.
Hyatt Regency Orlando, Regency Ballroom 5
Sponsored by Edwards Lifesciences

  Sunday, March 11
  Sunday, March 11

Morning Events

A Town Hall Series on Improving Access to PCSK9 Inhibitors
5:30 a.m. – 7:45 a.m.
Hyatt Regency Orlando
Sponsored by American Society for Preventive Cardiology

Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA, FASPC
President, American Society for Preventive Cardiology

Martha Gulati, MD, MS, FACC, FAHA, FASPC
Board Member, American Society for Preventive Cardiology

Michael Shapiro, DO, FASPC
Board Member, American Society for Preventive Cardiology

Join us to discuss gaining access to PCSK9 Inhibitors through a NEW mobile application created by the American Society for Preventive Cardiology. Learn how to use this new tool to overcome the hurdle in accessibility. This event is FREE to attend. Breakfast will be provided.

Evening Events

Reducing Cardiovascular Risk in Patients with Dyslipidemia: What do We Know Now? (And What Should We Do About It?)
Welcome Reception and Registration: 5:30 p.m. – 6:00 p.m.
Panel Discussion: 6:00 p.m. – 7:30 p.m.
Hyatt Regency Orlando, Plaza Ballroom D
Sponsored by PeerVoice

Kausik Ray, BSc (Hons), MBChB, FRCP, MD, MPhil (Cantab), FACC, FESC, FAHA; Professor of Public Health, Imperial College London, London, United Kingdom (Moderator)

Christopher P. Cannon, MD; Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA (Presenter/Panelist)

Michael H. Davidson, MD, FACC, FNLA; Professor, Director of the Lipid Clinic, The University of Chicago Pritzker School of Medicine Chicago, Illinois, USA (Presenter/Panelist)

Recent data on managing lipid-related cardiovascular risk have challenged many assumptions about the best way to manage dyslipidemia: How low is low enough for LDL-C? Do the benefits of intensified lipid-lowering strategies outweigh potential risks? How effective are current risk assessment models for identifying which patients may benefit from more intensive approaches to lipid lowering? Join us for this interactive Symposium as expert faculty weight the latest clinical evidence to address these key questions.

Interested in Hosting an Event?

ACC.18 exhibitors, universities, and non-profit organizations that wish to host an event during ACC.18 between Thursday, March 8 and Monday, March 12 should download and review the Ancillary Event Guidelines and submit a request to host an Ancillary Event by visiting the Ancillary Events Function Space Request page. Not an ACC.18 exhibitor? Become one today.

Non-profit organizations that wish to host an Independent Certified Session during ACC.18 must submit an application no later than Friday, December 1, 2017

Click here to download the Independent Certified Session Guidelines and Application Form.


Schedule is current as of Feb. 9, 2018, and is subject to change. Please check back for updates.

Prime Time Event presentations are not part of ACC.18, as planned by its Program Committee, and do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Advertisement

ACC Logo
ACC.18 on Social Media:
      
2017 American College of Cardiology Foundation. Visit ACC.org
Terms and Conditions Registered User Agreement Advertising and Sponsorship Policy Privacy Policy Contact Us